Information Library
Results for: Oncology - Late Phase
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Oncology Experience
Brochure — February 7, 2012
Quintiles acquires Outcome to offer full spectrum of inventional and observational research. Together, we offer the expertise and experience in real-world and late phase research -
Quintiles Joins the I-SPY 2 Breast Cancer Trial
Hear from the Experts — April 14, 2011
The I-SPY 2 clinical trial involves 800 patients with advanced breast cancer, and employs innovative adaptive trial design and genetic and biological markers from individual patients’ tumors to screen multiple investigational therapies simultaneously. -
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
Exclusive Report From Scientific American
Hear from the Experts — November 9, 2010
In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today. -
Targeting Oncology
Brochure — June 2, 2010
Learn more about Quintiles leadership in oncology product development and commercialization. -
Podcast: Changing the Face of Cancer Research
Hear from the Experts — August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Podcast: Changing the Face of Cancer Research
Hear from the Experts — August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development.
Page 1 of 1 (7 results)
